• Stichting IWO wordt bestuurd door artsen die werkzaam zijn in verschillende organisaties en specialismen, maar hetzelfde doel voor ogen hebben

  • Stichting IWO wordt bestuurd door artsen die werkzaam zijn in verschillende organisaties en specialismen, maar hetzelfde doel voor ogen hebben

Nieuws

Tweede IWO-webinar:

Op 18 november jl. organiseerde de IWO voor de 2e keer een webinar, met internationale sprekers en nog meer deelnemers dan bij de 1e webinar. U kunt hier klikken om de video van de webinar terug te kijken, het wachtwoord is iwo123.

 

Eerste IWO-Webinar is groot succes!

Door de corona-crisis gedwongen, werd de IWO-avond in Utrecht van 22 april 2020 afgezegd. In de plaats daarvan werd er een webinar georganiseerd, met een opvallend hoog aantal deelnemers: in Utrecht meestal tussen 60 en 80 deelnemers, nu 132!

Het geheel werd gepresenteerd door de IWO bestuursleden Prof. Dr. Marielle Emmelot-Vonk en Prof. Dr. Willem F. Lems, vanuit de professionele studio van AV-Brothers uit Amersfoort. Klik hier voor de video van de webinar.

 

Volg hier relevant internationaal nieuws over osteoporose. De nieuwsfeed bevat zowel doorgeplaatste artikelen, als publicaties uit de Osteoporose journalen. Klik hier voor rss-feeds.

 

  • Long-term risk of subsequent major osteoporotic fracture and hip fracture in men and women: a population-based observational study with a 25-year follow-up

    Osteoporos Int 2021 Jun 24. doi: 10.1007/s00198-021-06028-9.   Introduction:  The risk of subsequent fractures is increased following an index fracture, and declines over time. We aimed to determine... Lees meer

    Gepost op 25 juni 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • Osteoporosis, fracture, osteoarthritis & sarcopenia: A systematic review of circulating microRNA association

    Bone 2021 Jun 21;116068. Circulating microRNAs (c-miRs) show promise as biomarkers. This systematic review explores their potential association with age-related fracture/osteoporosis (OP), osteoarthritis (OA) and... Lees meer

    Gepost op 25 juni 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • Multiple vertebral fractures after suspension of denosumab. A series of 56 cases

    Int J clin Pract. 2021 Jun 19;e14550. Background:  Denosumab is a monoclonal antibody approved for the treatment of postmenopausal osteoporosis. The withdrawal of denosumab produces an abrupt loss of bone... Lees meer

    Gepost op 22 juni 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • Systematic review of major osteoporotic fracture to hip fracture incidence rate ratios worldwide: Implications to FRAX derived estimates

    J Bone Miner Res. 2021 Jun 21.doi: 10.1002/jbmr.4395. The Fracture Risk Assessment Tool (FRAX) is the most widely used tool for fracture prediction. It provides 10-year probabilities for hip and major osteoporotic... Lees meer

    Gepost op 22 juni 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • A Network Meta-Analysis Comparing Osteoporotic Fracture among Different Direct Oral Anticoagulants and Vitamin K Antagonists in Patients with Atrial Fibrillation

    J Bone Metab. 2021 May;28(2):139-150. Background:  There are limited studies comparing the risk of osteoporosis and fractures between different direct oral anticoagulants (DOACs) and vitamin K antagonists (VKA)... Lees meer

    Gepost op 16 juni 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism

    Osteoporos Int. 2021 Jun 15. doi: 10.1007/s00198-021-05975-7. The European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) CKD-MBD working group, in collaboration with the Committee of... Lees meer

    Gepost op 16 juni 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • Dietary calcium intake and change in bone mineral density in older adults: a systematic review of longitudinal cohort studies

    Eur J Clin Nutr. 2021 Jun 15. doi: 10.1038/s41430-021-00957-8. Many older adults do not achieve recommended intakes of calcium and there is some concern over the potential impact of this on bone health. The objective... Lees meer

    Gepost op 16 juni 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • Switching to denosumab or bisphosphonates after completion of teriparatide treatment in women with severe postmenopausal osteoporosis

    Endocr. Pract. 2021 Jun 7;S1530-891X(21)01077-6. Objective:  We compared bone mineral density (BMD) changes after 12 months' treatment with denosumab or bisphosphonates in postmenopausal women with severe... Lees meer

    Gepost op 12 juni 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • Analysis of the subsequent treatment of osteoporosis by transitioning from bisphosphonates to denosumab, using quantitative computed tomography: A prospective cohort study

    Bone Rep. 2021 May 7;14:101090. Purpose:  Denosumab reduces bone resorption and improves bone mineral density (BMD). Studies have analyzed subsequent treatment transitioning from bisphosphonates to denosumab... Lees meer

    Gepost op 12 juni 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • Risk of Subsequent Fractures in Postmenopausal Women After Nontraumatic vs Traumatic Fractures

    JAMA Intern Med. 2021 jun 7;e212617 Objective:  To determine how future fracture risk varies according to whether an initial fracture is traumatic or nontraumatic. Design, setting, and participants:  We... Lees meer

    Gepost op 10 juni 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • Dual-energy X-ray Absorptiometry Does Not Represent Bone Structure in Patients with Osteoporosis: A Comparison of Lumbar Dual-Energy X-Ray Absorptiometry with Vertebral Biopsies

    Spine. 2021 Jul 1;46(13):861-866. Study design:  Prospective cross-sectional exploratory study. Objective:  To evaluate the correlation between in vivo lumbar dual-energy x-ray absorptiometry (DXA)... Lees meer

    Gepost op 10 juni 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • SCOPE 2021: a new scorecard for osteoporosis in Europe

    Arch Osteoporos 2021;june 2;(16)1:82 Introduction:  The scorecard for osteoporosis in Europe (SCOPE) is a project of the International Osteoporosis Foundation (IOF) that seeks to raise awareness of osteoporosis care... Lees meer

    Gepost op 06 juni 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • Fracture Incidence and the Relevance of Dietary and Lifestyle Factors Differ in the United Kingdom and Hong Kong: An International Comparison of Longitudinal Cohort Study Data

    Calcif Tissue Int. 2021 Jun 3. doi: 10.1007/s00223-021-00870-z. Online ahead of print.   Geographic variation in fracture risk may be due to divergent profiles of dietary, lifestyle, and other risk factors... Lees meer

    Gepost op 06 juni 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • Patient Outcomes in the Years After a DXA-BMD Treatment Monitoring Test: Improved Medication Adherence in Some, But Too Little Too Late

    J Bone Miner Res. 2021 May 24.doi: 10.1002/jbmr.4333. The role of mid-treatment monitoring dual-energy X-ray absorptiometry-bone mineral density (DXA-BMD) for bisphosphonate-treated patients with osteoporosis remains... Lees meer

    Gepost op 25 mei 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • Effects of prior osteoporosis treatment on 12-month treatment response of romosozumab in patients with postmenopausal osteoporosis

    Joint Bone Spine. 2021 May 18;105219.    Objectives: To investigate the effects of prior treatment and determine the predictors of a 12-month treatment response of romosozumab (ROMO) in 148 patients... Lees meer

    Gepost op 24 mei 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • Is there a potential dual effect of denosumab for treatment of osteoporosis and sarcopenia?

    Clin Rheumatol. 2021 May 19.doi: 10.1007/s10067-021-05757-w. Background: The prevalence of sarcopenia with osteoporosis results in a higher risk of falling and fractures. It was noted that patients who had... Lees meer

    Gepost op 21 mei 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • Alterations of bone markers in obese patients with type 2 diabetes after bariatric surgery: A meta-analysis and systemic review of randomized controlled trials and cohorts

    Medicine (Baltimore). 2021 May 21;100(20):e26061. Background: The aim of this study is to evaluate the alterations in bone mineral density and other surrogate markers for osteoporosis in obese patients with... Lees meer

    Gepost op 21 mei 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • Treatment of bone fragility in patients with diabetes: antiresorptive versus anabolic?

    Curr Opin Endocrinol Diabetes Obes. 2021 May 19.doi: 10.1097/MED.0000000000000645. Purpose of review: The pathogenesis of bone fragility in diabetes has not been fully characterized. The antifracture efficacy of... Lees meer

    Gepost op 21 mei 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • Fractures After Denosumab Discontinuation: A Retrospective Study of 797 Cases

    J Bone Miner Res. 2021 May 19. doi: 10.1002/jbmr.4335. A rebound of osteoclast activity during the 2 years after a treatment or prevention of osteoporosis with denosumab (Dmab) leads to an increased risk of... Lees meer

    Gepost op 21 mei 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study

    Bone Rep. 2021 Apr 16;14:101068. Real-world data on the new anti-sclerostin antibody drug, romosozumab, remain scarce. There is a strong need to accumulate and analyze data on romosozumab treatment for such... Lees meer

    Gepost op 16 mei 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • Bone density and quality in patients treated with direct-acting oral anticoagulants versus warfarin

    Bone. 2021 May 8;150:116000. Introduction: Direct-acting oral anticoagulants (DOACs) are therapeutic alternatives to warfarin that act independently of vitamin K, thus not affecting bone matrix formation. The... Lees meer

    Gepost op 13 mei 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • The duration of denosumab treatment and the efficacy of zoledronate to preserve bone mineral density after its discontinuation

    J Clin Endocrinol Metab. 2021 May 12;dgab321. Context: Zoledronate is used to prevent bone loss following denosumab discontinuation but its efficacy differs among studies. Objective: To test if the... Lees meer

    Gepost op 13 mei 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • Improving Bone Health by Optimizing the Anabolic Action of Wnt Inhibitor Multitargeting

    JBMR Plus. 2021 May 6;5(5):e10462. Sclerostin antibody (romosozumab) was recently approved for clinical use in the United States to treat osteoporosis. We and others have explored Wnt-based combination therapy to... Lees meer

    Gepost op 13 mei 2021

    Bron: https://pubmed.ncbi.nlm.nih....

  • Internal medicine inpatients' prevalence of misdiagnosed severe osteoporosis

    Osteoporos Int. 2021 May 5. doi: 10.1007/s00198-021-05976-6. Introduction: Vertebral fractures (VFs) related to osteoporosis (OP) increase the risk of additional fractures and death. In inpatients, VFs are... Lees meer

    Gepost op 07 mei 2021

    Bron: https://pubmed.ncbi.nlm.nih....

Sponsors & Partners